INC Research Holdings Inc (SYNH)
$42.98
$0.00 (0.00%)As on 29-Sep-2023 09:30EDT
Market cap
$4,458 Mln
Revenue (TTM)
$5,419 Mln
P/E Ratio
61.4
P/B Ratio
1.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$71 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
9.1
-
Debt to Equity
0.8
-
Book Value
$--
-
EPS
$0.7
-
Face value
--
-
Shares outstanding
103,719,000
10 Years Aggregate
CFO
$2,605.73 Mln
EBITDA
$4,091.73 Mln
Net Profit
$875.87 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
INC Research Holdings Inc (SYNH)
| 17.2 | 1.0 | 1.9 | -10.2 | -7.0 | -3.6 | -- |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
INC Research Holdings Inc (SYNH)
| -64.3 | 50.7 | 14.6 | 51.1 | -9.7 | -17.1 | 8.4 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
INC Research Holdings Inc (SYNH)
|
43.0 | 4,457.8 | 5,419.0 | 71.2 | 5.6 | 2 | 61.4 | 1.1 |
| 84.8 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 72.4 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 59.0 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 110.2 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 355.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 118.2 | 9,718.7 | 105.0 | -299.7 | -227.2 | -19.4 | -- | 6.6 | |
| 541.4 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 592.0 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 124.0 | 9,808.7 | 0.0 | -450.1 | -- | -44.6 | -- | 8.4 |
Shareholding Pattern
View DetailsAbout INC Research Holdings Inc (SYNH)
Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of... diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private. Read more
-
CEO & Director
Ms. Michelle Keefe
-
CEO & Director
Ms. Michelle Keefe
-
Headquarters
Morrisville, NC
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for INC Research Holdings Inc (SYNH)
What is the current share price of INC Research Holdings Inc (SYNH) Today?
The share price of INC Research Holdings Inc (SYNH) is $42.98 (NASDAQ) as of 29-Sep-2023 09:30 EDT. INC Research Holdings Inc (SYNH) has given a return of -6.97% in the last 3 years.
What is the current PB & PE ratio of INC Research Holdings Inc (SYNH)?
The P/E ratio of INC Research Holdings Inc (SYNH) is 61.40 times as on 29-Sep-2023.
The P/B ratio of INC Research Holdings Inc (SYNH) is 1.07 times as on 29-Sep-2023, a 79 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
14.21 |
1.08 |
2021 |
45.91 |
3.16 |
2020 |
37.25 |
2.22 |
2019 |
47.75 |
2.07 |
2018 |
169.85 |
1.44 |
What is the 52 Week High and Low of INC Research Holdings Inc (SYNH)?
The 52-week high and low of INC Research Holdings Inc (SYNH) are Rs -- and Rs -- as of 05-Sep-2026.
What is the market cap of INC Research Holdings Inc (SYNH)?
INC Research Holdings Inc (SYNH) has a market capitalisation of $ 4,458 Mln as on 29-Sep-2023. As per SEBI classification, it is a company.
Should I invest in INC Research Holdings Inc (SYNH)?
Before investing in INC Research Holdings Inc (SYNH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.